Ep. 85: “Killer Antibodies” Featuring Dr. Christopher Park
Dr. Christopher Park is an Associate Professor and Director of Pathology Education and Translational Research at the NYU Langone Medical center. His lab is currently looking at new ways to combat blood cancers like leukemia by attacking and destroying the blood stem cells. In this episode, Dr. Park discusses his lab’s work and the details of their most recent publication in Science Translational Medicine.
Resources and Links
Scientists Plan to March – A few months from now, thousands of scientists will leave their labs and take to the streets to rally on behalf of publicly funded, openly communicated, evidence-based research.
CRISPR Used in Cows to Help Fight Tuberculosis – Researchers are able to obtain transgenic cattle with increased resistance to tuberculosis through somatic cell nuclear transfer.
An Artist’s Amnesia Could Help Better Understand Memory – Despite having amnesia, artist Lonni Sue Johnson can still create art, which makes neuroscientists curious about Johnson’s brain in part because her education and expertise before her illness contrast sharply with that of the most famous amnesiac known to science, Henry Molaison.
Shining Light on Eggs Leads to More “Chilled” Out Chickens – Researchers at the University of California, Davis found that broilers given at least 12 hours of light daily during incubation were less fearful.
First Human-Pig ‘Chimera’ Created in Milestone Study – Scientists from the Salk Institute have created a human-pig hybrid in a milestone study that raises the prospect of being able to grow human organs inside animals for use in transplants.
Study by Cleveland Clinic Researchers Explains How Brain Cancer Cells Avoid Immune System – A new study by Cleveland Clinic researchers has uncovered some of the mystery behind what enables glioblastoma – one of the most deadly and recurring brain cancers – to resist most cancer treatments, including chemotherapy, radiation and immunotherapy.
Endocrinology Stem Cell Research Engineering Thyroid Cells from Stem Cells May Lead to New Therapies – Researchers found a way to coax genetically modified embryonic stem cells from mice to develop into thyroid cells.
Direct Reprogramming of Mouse Fibroblasts toward Leydig-like Cells by Defined Factors – Induced Leydig-like cells (iLCs) expressed steroidogenic genes, had a global gene expression profile similar to that of adult LCs, and acquired androgen synthesis capabilities.
Photo Reference: Courtesy of Dr. Christopher Park